+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormonal Contraceptives Global Market Report 2020

  • ID: 4856026
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
Hormonal Contraceptives Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global hormonal contraceptives market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the hormonal contraceptives? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hormonal Contraceptives Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Product: Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Others 2) By End Users: Hospitals, Homecare Settings, Gynaecology Centers, Clinics, Ambulatory surgical centers
  • Companies Mentioned: Bayer AG, Merck & Co. Inc., Pfizer, Allergan, Afaxys Inc.
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
1. Executive Summary

2. Hormonal Contraceptives Market Characteristics

3. Hormonal Contraceptives Market Size And Growth
3.1. Global Hormonal Contraceptives Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Hormonal Contraceptives Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Hormonal Contraceptives Market Segmentation
4.1. Global Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral Contraceptive Pills Injectable Birth Control
  • Emergency Contraceptive Pills Vaginal Rings
  • Others
4.2. Global Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospitals Homecare Settings
  • Gynaecology Centers Clinics
  • Ambulatory surgical centers
5. Hormonal Contraceptives Market Regional And Country Analysis
5.1. Global Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Hormonal Contraceptives Market
6.1. Asia-Pacific Hormonal Contraceptives Market Overview
6.2. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Hormonal Contraceptives Market
7.1. China Hormonal Contraceptives Market Overview
7.2. China Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Hormonal Contraceptives Market
8.1. India Hormonal Contraceptives Market Overview
8.2. India Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Hormonal Contraceptives Market
9.1. Japan Hormonal Contraceptives Market Overview
9.2. Japan Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Hormonal Contraceptives Market
10.1. Australia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Hormonal Contraceptives Market
11.1. Indonesia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Hormonal Contraceptives Market
12.1. South Korea Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Hormonal Contraceptives Market
13.1. Western Europe Hormonal Contraceptives Market Overview
13.2. Western Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Hormonal Contraceptives Market
14.1. UK Hormonal Contraceptives Market Overview
14.2. UK Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Hormonal Contraceptives Market
15.1. Germany Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Hormonal Contraceptives Market
16.4. France Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Hormonal Contraceptives Market
17.1. Eastern Europe Hormonal Contraceptives Market Overview
17.2. Eastern Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Hormonal Contraceptives Market
18.1. Russia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Hormonal Contraceptives Market
19.1. North America Hormonal Contraceptives Market Overview
19.2. North America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Hormonal Contraceptives Market
20.1. USA Hormonal Contraceptives Market Overview
20.2. USA Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Hormonal Contraceptives Market
21.1. South America Hormonal Contraceptives Market Overview
21.2. South America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Hormonal Contraceptives Market
22.1. Brazil Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Hormonal Contraceptives Market
23.1. Middle East Hormonal Contraceptives Market Overview
23.2. Middle East Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Hormonal Contraceptives Market
24.1. Africa Hormonal Contraceptives Market Overview
24.2. Africa Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Hormonal Contraceptives Market Competitive Landscape And Company Profiles
25.1. Hormonal Contraceptives Market Competitive Landscape
25.2. Hormonal Contraceptives Market Company Profiles
25.2.1. Bayer AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Merck & Co. Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Pfizer
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Allergan
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Afaxys Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Hormonal Contraceptives Market

27. Hormonal Contraceptives Market Trends And Strategies

28. Product Pipeline Analysis

29. Hormonal Contraceptives Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
The hormonal contraceptives market consists of sale of hormonal contraceptives and related services. Hormonal contraceptives are used as a birth control method that acts on the endocrine system of the human body.

The global hormonal contraceptives market was valued at about $13.36 billion in 2018 and is expected to grow to $15.39 billion at a CAGR of 3.6% through 2022.

Increased awareness about the benefits and use of contraceptives is a major factor driving the hormonal contraceptives market. According to the World Health Organization (WHO), 16 million girls worldwide aged 15-19 give birth every year which accounts to approximately 11% of all births globally. In order to prevent these unplanned births global awareness programs such as ""Its your life, its your future"" by the WHO and world contraception day were initiated. The London Summit on Family Planning urged governments, international agencies, and other private sector to commit to improving access to voluntary family planning. This gave rise to the global partnership, Family Planning 2020 (FP2020). FP2020 has created a momentum worldwide on issues such as access to contraceptives, more innovation, and greater accountability in family planning efforts. For example, India committed to spend USD$3 billion by 2020 to spread awareness improve family planning in the country. Moreover, in 2015, it was estimated that approximately 64% of married women aged between 15 and 49 used either a modern or traditional method of family planning, an increase from 36% in 1970.

The market for hormonal contraceptive drugs is restrained by the growing use of biologics in place of traditional chemical drugs. Biologics are the medicines containing one or more substances derived from a biological source like micro-organisms, animal cells or human cells. The ability to interact with specific targets puts these medicines above any other drugs, thus hampering the market of chemical hormonal contraceptive drugs.

Companies are innovating to manufacture chewable low dose oral contraceptives that reduce side effects. Chewable contraceptive initiative was an attempt to reduce side effects while at the same time making it easier for the patients to get into a daily regimen of using this contraceptive. The pill is already being sold as an over the counter product. Some of the top companies that produce and sell chewable low-dose oral contraceptives, for instance, are Lupin pharmaceuticals, Walter Chilcott and Watson pharmaceuticals.

Manufacturers in the hormonal contraceptives market should abide by many strict regulations with regards to labeling hormonal contraceptives, and are all supervised by regulatory authorities. For instance, in 2018, the US FDA has drafted a new set of guidance and labelling recommendations in the hormonal contraceptives market, and have to be in accordance with the 2006 physician labeling rule (PLR) and the 2014 pregnancy and lactation labeling rule (PLLR). The main purpose of PLR is to enhance the safety and usage of the particular prescribed drug by providing healthcare providers clear prescription information (PI). The FDA mandates all hormonal contraceptives to mention the effectiveness of the drug from preventing STDs, and any other relevant information regarding effectiveness of the drug. The FDA considers that communicating information regarding pregnancy rates to the users of these contraceptive drugs is essential for safety and effective usage.

Major players in the market are Bayer AG, Merck & Co. Inc., Pfizer, Allergan and Afaxys Inc.
Note: Product cover images may vary from those shown
5 of 5
  • Bayer AG
  • Merck & Co. Inc.
  • Pfizer
  • Allergan
  • Afaxys Inc.
  • Teva Pharma Industries Ltd.
  • Agile Therapeutics
  • HLL Lifecare Limited
  • Lupin Pharmaceuticals Inc.
  • Piramal Healthcare Limited
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Apothecus Pharmaceutical Corporation
  • Amgen
  • Ansell Limited
  • Church & Dwight Co
  • Johnson & Johnson
  • Mayer Laboratories
  • Famy care
  • Mylan Laboratories
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll